Ownership history in UBS Group AG · 3 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in QUALIGEN THERAPEUTICS INC (QLGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 5,373 | +2,221 | +70.5% | 0.00% | $13K | — |
| 2025 Q3 | ADDED | 3,152 | +2,652 | +530.4% | 0.00% | $18K | — |
| 2024 Q4 | INITIATED | 500 | — | — | 0.00% | $2K | — |
As of 2025 Q4 — sorted by position size